Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

IOXILAN: 119 Adverse Event Reports & Safety Profile

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now
119
Total FAERS Reports
1 (0.8%)
Deaths Reported
30
Hospitalizations
119
As Primary/Secondary Suspect
4
Life-Threatening
Dec 21, 1995
FDA Approved
Discontinued
Status

FDA Application: 020316 ·

First Report: 20020301 · Latest Report: 20150603

What Are the Most Common IOXILAN Side Effects?

#1 Most Reported
Urticaria
36 reports (30.3%)
#2 Most Reported
Vomiting
19 reports (16.0%)
#3 Most Reported
Pruritus
16 reports (13.4%)

All IOXILAN Side Effects by Frequency

Side Effect Reports % of Total Deaths Hosp.
Urticaria 36 30.3% 0 4
Vomiting 19 16.0% 0 0
Pruritus 16 13.5% 1 1
Nausea 15 12.6% 0 0
Hypersensitivity 12 10.1% 0 1
Rash 11 9.2% 0 2
Contrast media reaction 8 6.7% 1 0
Dyspnoea 8 6.7% 1 2
Sneezing 8 6.7% 0 1
Throat tightness 8 6.7% 0 2
Chest pain 7 5.9% 0 3
Hypotension 5 4.2% 1 2
Post procedural haematoma 5 4.2% 0 5

Who Reports IOXILAN Side Effects? Age & Gender Data

Gender: 53.8% female, 46.2% male. Average age: 52.0 years. Most reports from: US. View detailed demographics →

Is IOXILAN Getting Safer? Reports by Year

YearReportsDeathsHosp.
2002 13 1 0
2003 13 0 2
2004 11 0 0
2005 4 0 0
2006 2 0 0
2007 19 0 5
2008 5 0 0
2009 9 0 1
2010 9 0 1
2011 2 0 0
2012 5 0 0
2014 2 0 2
2015 2 0 2

View full timeline →

What Is IOXILAN Used For?

IndicationReports
Computerised tomogram 41
Percutaneous coronary intervention 19
Angiogram 7

IOXILAN vs Alternatives: Which Is Safer?

IOXILAN vs IPTACOPAN IOXILAN vs ISOSORBIDE DINITRATE IOXILAN vs IVABRADINE IOXILAN vs KARDEGIC IOXILAN vs KETOPROFEN IOXILAN vs LACTULOSE IOXILAN vs LANSOPRAZOLE IOXILAN vs LENALIDOMIDE IOXILAN vs LETAIRIS IOXILAN vs LEUPROLIDE

Official FDA Label for IOXILAN

Official prescribing information from the FDA-approved drug label.